Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Drug Resistance, Bacterial/drug effects"'
Autor:
Shukla, Rhythm, Lavore, Francesca, Maity, Sourav, Derks, Maik G.N., Jones, Chelsea R., Vermeulen, Bram J.A., Melcrová, Adéla, Morris, Michael A., Becker, Lea Marie, Wang, Xiaoqi, Kumar, Raj, Medeiros-Silva, João, van Beekveld, Roy A.M., Bonvin, Alexandre M.J.J., Lorent, Joseph H., Lelli, Moreno, Nowick, James S., MacGillavry, Harold D., Peoples, Aaron J., Spoering, Amy L., Ling, Losee L., Hughes, Dallas E., Roos, Wouter H., Breukink, Eefjan, Lewis, Kim, Weingarth, Markus, Sub NMR Spectroscopy, Sub Membrane Biochemistry & Biophysics, Sub Cell Biology, NMR Spectroscopy, Celbiologie, Membrane Biochemistry and Biophysics
Publikováno v:
Nature, 608(7922), 390. Nature Research
Nature
Nature, 608(7922), 390-396. Nature Publishing Group
Nature
Nature, 608(7922), 390-396. Nature Publishing Group
Antibiotics that use novel mechanisms are needed to combat antimicrobial resistance1–3. Teixobactin4 represents a new class of antibiotics with a unique chemical scaffold and lack of detectable resistance. Teixobactin targets lipid II, a precursor
Autor:
Ouchar Mahamat, Oumar, Lounnas, Manon, Hide, Mallorie, Dumont, Yann, Tidjani, Abelsalam, Kamougam, Kadidja, Abderrahmane, Madina, Benavides, Julio, Solassol, Jérôme, Bañuls, Anne-Laure, jean-Pierre, Hélène, Carrière, Christian, Godreuil, Sylvain
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-7 (2019)
BMC Infectious Diseases
BMC Infectious Diseases, BioMed Central, 2019, 19 (1), pp.205. ⟨10.1186/s12879-019-3838-1⟩
BMC Infectious Diseases, 2019, 19 (1), pp.205. ⟨10.1186/s12879-019-3838-1⟩
BMC Infectious Diseases
BMC Infectious Diseases, BioMed Central, 2019, 19 (1), pp.205. ⟨10.1186/s12879-019-3838-1⟩
BMC Infectious Diseases, 2019, 19 (1), pp.205. ⟨10.1186/s12879-019-3838-1⟩
Background Extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) represent a major problem in the management of nosocomial infections. However, ESBL-PE are not systematically monitored in African countries. The aim of this study was t
Antibiotic resistance in pathogen microorganisms is a major global concern, especially the formation of biofilms. Quorum quenching has been practically used to control biofilm growth, and this indicates a promising hope for the development of new dru
Autor:
TOMISLAV MEŠTROVIĆ, AMARELA LUKIĆ-GRLIĆ, MAJA BOGDAN, DANIELA BANDIĆ- PAVLOVIĆ, GORDANA CAVRIĆ, DOMAGOJ DRENJANČEVIĆ, KATHERINA BERNARDETTE SRETER, ANA BENČIĆ, SANDA SARDELIĆ, BRANKA BEDENIĆ
Publikováno v:
Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske
Volume 72
Issue 3
Volume 72
Issue 3
Proteus mirabilis (P. mirabilis) je sve značajniji uzročnik bolničkih i izvanbolničkih infekcija – uključujući i infekcije u domovima za starije i nemoćne osobe. Prethodna istraživanja rezistencije u P. mirabilis u Hrvatskoj su pokazala dom
Autor:
Stephanie Bjerrum, Mercy J. Newman, Christabel Enweronu-Laryea, Noah Obeng-Nkrumah, Appiah Korang Labi
Publikováno v:
Labi, A-K, Obeng-Nkrumah, N, Bjerrrum, S, Enweronu-Laryea, C & Newman, M J 2016, ' Neonatal bloodstream infections in a Ghanaian Tertiary Hospital : Are the current antibiotic recommendations adequate? ', BMC Infectious Diseases, vol. 16, 598 . https://doi.org/10.1186/s12879-016-1913-4
BMC Infectious Diseases, Vol 16, Iss 1, Pp 1-12 (2016)
BMC Infectious Diseases
BMC Infectious Diseases, Vol 16, Iss 1, Pp 1-12 (2016)
BMC Infectious Diseases
Background Diagnosis of bloodstream infections (BSI) in neonates is usually difficult due to minimal symptoms at presentation; thus early empirical therapy guided by local antibiotic susceptibility profile is necessary to improve therapeutic outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c688e3c3ed8b727717aa763b7dbe5232
https://findresearcher.sdu.dk:8443/ws/files/124238825/Neonatal_bloodstream_infections_in_a_Ghanaian_Tertiary_Hospital.pdf
https://findresearcher.sdu.dk:8443/ws/files/124238825/Neonatal_bloodstream_infections_in_a_Ghanaian_Tertiary_Hospital.pdf
Autor:
Irena, Franolić-Kukina, Sanda, Sardelić, Nataša, Beader, Dijana, Varda-Brkić, Nataša, Firis, Marko, Čačić, Dorotea, Šijak, Sonja, Frančula-Zaninović, Vesna, Elveđi-Gašparović, Ivana, Mareković, Amarela, Lukić-Grlić, Mihaela, Ajman, Branka, Bedenić
Publikováno v:
Liječnički vjesnik
Volume 138
Issue 9-10
Volume 138
Issue 9-10
Rezistencija na cefalosporine proširenog spektra u Enterobacter spp. nastaje zbog indukcije ili derepresije AmpC-β-laktamaze, produkcije β-laktamaza proširenog spektra (ESBL) ili karbapenemaza. Cilj istraživanja bio je utvrditi mehanizme reziste
Autor:
Sandra Sousa, Rita Pombinho, Filipe Carvalho, Richard Gallo, Gonçalo Covas, Sergio Raposo Filipe, Didier Cabanes, Giulia Gasparini, Magda Atilano
Publikováno v:
PLoS pathogens, vol 11, iss 5
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
PLoS Pathogens, Vol 11, Iss 5, p e1004919 (2015)
PLoS Pathogens
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
PLoS Pathogens, Vol 11, Iss 5, p e1004919 (2015)
PLoS Pathogens
Listeria monocytogenes is an opportunistic Gram-positive bacterial pathogen responsible for listeriosis, a human foodborne disease. Its cell wall is densely decorated with wall teichoic acids (WTAs), a class of anionic glycopolymers that play key rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1951a493c7bc24c791c103221d9e29ce
https://hdl.handle.net/10216/114513
https://hdl.handle.net/10216/114513
Autor:
Louis Bernard, Patrice Francois, Daniel Pablo Lew, Jacques Schrenzel, Adriana Renzoni, Marta Buzzi, Stéphan Juergen Harbarth, Pierre Vaudaux, Tristan Ferry, Elzbieta Huggler, Ilker Uçkay
Publikováno v:
Antimicrobial Agents and Chemotherapy, Vol. 56, No 3 (2012) pp. 1258-64
Antimicrobial agents and chemotherapy
Antimicrobial agents and chemotherapy
Reduced susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates is considered a risk factor for failure of glycopeptide therapy. We compared the prevalences of MRSA isolates with reduced glycopeptide su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25afb08dba1d5f3766fb2b2403ade32d
https://archive-ouverte.unige.ch/unige:25168
https://archive-ouverte.unige.ch/unige:25168
Autor:
Patricia Sheen, Daniela E. Kirwan, Andres H. Gutierrez, Robert H. Gilman, Mirko Zimic, Patricia Fuentes
Publikováno v:
Tuberculosis (Edinburgh, Scotland). 92(1)
Summary Pyrazinamide is one of the most important drugs in the treatment of latent Mycobacterium tuberculosis infection. The emergence of strains resistant to pyrazinamide represents an important public health problem, as both first- and second-line